Clinical Trials

Certolizumab in psoriasis

Certolizumab pegol improved health-related quality of life in patients with psoriasis: Data from a phase II study

to Continue Reading, Login Now

Please Login

If you are a registered user but you have forgotten your password, please click here
If you are not a registered user, please register here